Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer|December 20, 2011
Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782J Paul Monk, Susan Halabi, Joel Picus, et al.Urologic Oncology|March 13, 2021
STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancerAnn Taber, Youngrok Park, Alana Lelo, et al.Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|September 27, 2021
Long-term Outcome of Per-oral Endoscopic Myotomy Performed in the Endoscopy Unit With TraineesMohamed M Abdelfatah, Lucie F Calderon, Amol Koldhekar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2018
STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder CancerAlana Lelo, Frederik Prip, Brent T Harris, et al.Gut|March 20, 2012
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver diseaseWing-Kin Syn, Kolade M Agboola, Marzena Swiderska, et al.Biorxiv : the Preprint Server for Biology|January 23, 2026
Longitudinal analysis of matched patient biospecimens reveals Neural Reprogramming of Cancer-Associated Fibroblasts Following Chemotherapy in Pancreatic Ductal AdenocarcinomaAylin Z Henstridge, Nandini Arya, Ahmed M Elhossiny, et al.Biorxiv : the Preprint Server for Biology|April 1, 2025
Spatial analysis of IPMNs defines a paradoxical KRT17-positive, low-grade epithelial population harboring malignant featuresJay Li, Justin Macchia, Ahmed M Elhossiny, et al.Cellular and Molecular Gastroenterology and Hepatology|February 4, 2026
Spatial analysis of IPMNs defines a paradoxical KRT17-positive, low-grade epithelial population harboring malignant featuresJay Li, Georgina Branch, Justin Macchia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2020
Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial CancerMatthew D Galsky, Amir Mortazavi, Matthew I Milowsky, et al.Pageof 2